Myelodysplastic syndromes anemia refractory with excess of blasts. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy21

Chromosomes, Human, Pair 5 Bone Marrow Chromosomes, Human, Pair 7 Bone Marrow Cells Granulocyte Precursor Cells Hematopoietic Stem Cells Erythroid Precursor Cells Erythroblasts Chromosomes, Human, Pair 8 Antilymphocyte Serum Erythroid Cells Chromosomes, Human, Pair 20 Isochromosomes Myeloid Progenitor Cells Granulocytes Megakaryocytes Chromosomes, Human, Pair 21 Clone Cells Chromosomes, Human, Pair 3 Blood Cells K562 Cells

Organisms1

Infectious Anemia Virus, Equine

Diseases68

Myelodysplastic Syndromes Anemia, Refractory Anemia, Refractory, with Excess of Blasts Anemia Syndrome Leukemia, Myeloid, Acute Leukemia, Myelomonocytic, Chronic Anemia, Aplastic Anemia, Sideroblastic Leukemia, Myeloid Chromosome Aberrations Monosomy Myeloproliferative Disorders Preleukemia Pancytopenia Anemia, Macrocytic Myelodysplastic-Myeloproliferative Diseases Acute Disease Blast Injuries Anemia, Hemolytic Fanconi Anemia Leukemia Chromosome Deletion Bone Marrow Diseases Iron Overload Neoplasms, Second Primary Anemia, Hemolytic, Autoimmune Trisomy Thrombocytopenia Anemia, Hypochromic Recurrence Anemia, Pernicious Hematologic Diseases Down Syndrome Disease Progression Blast Crisis Metabolic Syndrome X Primary Myelofibrosis Anemia, Sickle Cell Leukemia, Myelogenous, Chronic, BCR-ABL Positive Sweet Syndrome Chromosome Disorders Translocation, Genetic Leukemia, Myelomonocytic, Acute Hematologic Neoplasms Anemia, Diamond-Blackfan Hemoglobinuria, Paroxysmal Thrombocytosis Anemia, Megaloblastic Isochromosomes Precursor Cell Lymphoblastic Leukemia-Lymphoma Cell Transformation, Neoplastic Neutropenia Graft vs Host Disease Nephrotic Syndrome Red-Cell Aplasia, Pure Leukemia, Radiation-Induced Sjogren's Syndrome Abnormal Karyotype Lymphoma, Non-Hodgkin Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Uniparental Disomy Pyoderma Gangrenosum Anemia, Hemolytic, Congenital Polychondritis, Relapsing Systemic Vasculitis Equine Infectious Anemia Turner Syndrome

Chemicals and Drugs39

Azacitidine Thalidomide Erythropoietin Antimetabolites, Antineoplastic Cytarabine Antineoplastic Agents Hematologic Agents Antigens, CD34 Hematinics Vidarabine Hemoglobins Granulocyte Colony-Stimulating Factor Core Binding Factor Alpha 2 Subunit Antilymphocyte Serum Iron Chelating Agents Arabinonucleosides Busulfan Immunosuppressive Agents Idarubicin DNA Modification Methylases HLA-DR Serological Subtypes Cyclophosphamide Iron Ferritins Ribonucleoprotein, U2 Small Nuclear fms-Like Tyrosine Kinase 3 Recombinant Proteins Sialic Acid Binding Ig-like Lectin 3 Dual Specificity Phosphatase 2 Thrombopoietin Antibodies, Monoclonal Antineoplastic Agents, Alkylating Granulocyte-Macrophage Colony-Stimulating Factor Antigens, CD Amifostine Receptors, Thrombopoietin Benzoates Oncogene Proteins, Fusion Aspartate Aminotransferase, Cytoplasmic

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Karyotyping Treatment Outcome Prognosis Cytogenetic Analysis Hematopoietic Stem Cell Transplantation Erythrocyte Transfusion Remission Induction Blood Transfusion Survival Analysis Transplantation, Homologous Blood Cell Count Chelation Therapy Survival Rate Bone Marrow Examination Retrospective Studies Transplantation Conditioning Antineoplastic Combined Chemotherapy Protocols In Situ Hybridization, Fluorescence Risk Factors Bone Marrow Transplantation Flow Cytometry Drug Administration Schedule Follow-Up Studies Immunophenotyping Fatal Outcome Disease-Free Survival Transplantation, Autologous DNA Mutational Analysis Platelet Count Cohort Studies Leukocyte Count Drug Therapy, Combination Salvage Therapy Prospective Studies Colony-Forming Units Assay Case-Control Studies Risk Combined Modality Therapy Whole-Body Irradiation Kaplan-Meier Estimate Erythrocyte Count Hematologic Tests Polymerase Chain Reaction Incidence Clinical Trials as Topic Chromosome Banding Severity of Illness Index Risk Assessment Injections, Subcutaneous Drug Evaluation Infusions, Intravenous Stem Cell Transplantation Maximum Tolerated Dose

Phenomena and Processes34

Chromosomes, Human, Pair 5 Chromosome Aberrations Monosomy Chromosomes, Human, Pair 7 Chromosome Deletion Trisomy Blood Cell Count Mutation Hematopoiesis Erythropoiesis Chromosomes, Human, Pair 8 Translocation, Genetic Refractory Period, Electrophysiological Karyotype Haploinsufficiency Time Factors Chromosomes, Human, Pair 20 Isochromosomes Platelet Count DNA Methylation Leukocyte Count Risk Apoptosis Dose-Response Relationship, Drug Chromosomes, Human, Pair 21 Phenotype Abnormal Karyotype Uniparental Disomy Erythrocyte Count Base Sequence Chromosomes, Human, Pair 3 Immunologic Surveillance Cell Differentiation Maximum Tolerated Dose

Disciplines and Occupations2

Cytogenetics Hematology

Information Science5

Survival Rate Fatal Outcome Molecular Sequence Data Incidence Base Sequence

Health Care19

Treatment Outcome Survival Analysis Survival Rate Retrospective Studies Risk Factors Follow-Up Studies Fatal Outcome Disease-Free Survival Cohort Studies Prospective Studies Case-Control Studies Risk Kaplan-Meier Estimate Incidence Clinical Trials as Topic Age Factors Severity of Illness Index Risk Assessment World Health Organization

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Myelodysplastic Syndromes Anemia, Refractory Anemia, Refractory, with Excess of Blasts Anemia Syndrome Leukemia, Myeloid, Acute Leukemia, Myelomonocytic, Chronic Anemia, Aplastic Anemia, Sideroblastic Leukemia, Myeloid Chromosomes, Human, Pair 5 Bone Marrow Azacitidine Karyotyping Chromosome Aberrations Thalidomide Monosomy Myeloproliferative Disorders Preleukemia Treatment Outcome Pancytopenia Anemia, Macrocytic Myelodysplastic-Myeloproliferative Diseases Prognosis Chromosomes, Human, Pair 7 Acute Disease Blast Injuries Cytogenetic Analysis Anemia, Hemolytic Bone Marrow Cells Fanconi Anemia Leukemia Erythropoietin Granulocyte Precursor Cells Chromosome Deletion Hematopoietic Stem Cell Transplantation Bone Marrow Diseases Iron Overload Erythrocyte Transfusion Neoplasms, Second Primary Antimetabolites, Antineoplastic Cytarabine Anemia, Hemolytic, Autoimmune Remission Induction Blood Transfusion Survival Analysis Cytogenetics Trisomy Hematopoietic Stem Cells Transplantation, Homologous Antineoplastic Agents Thrombocytopenia Hematologic Agents Antigens, CD34 Blood Cell Count Anemia, Hypochromic Mutation Chelation Therapy Survival Rate Bone Marrow Examination Recurrence Hematinics Retrospective Studies Vidarabine Hematopoiesis Transplantation Conditioning Anemia, Pernicious Hematologic Diseases Down Syndrome Disease Progression Hemoglobins Granulocyte Colony-Stimulating Factor Blast Crisis Antineoplastic Combined Chemotherapy Protocols Erythropoiesis Metabolic Syndrome X Erythroid Precursor Cells In Situ Hybridization, Fluorescence Risk Factors Bone Marrow Transplantation Primary Myelofibrosis Flow Cytometry Anemia, Sickle Cell Leukemia, Myelogenous, Chronic, BCR-ABL Positive Erythroblasts Chromosomes, Human, Pair 8 Core Binding Factor Alpha 2 Subunit Sweet Syndrome Chromosome Disorders Antilymphocyte Serum Translocation, Genetic Drug Administration Schedule Follow-Up Studies Immunophenotyping Refractory Period, Electrophysiological Leukemia, Myelomonocytic, Acute Hematologic Neoplasms Fatal Outcome Karyotype Anemia, Diamond-Blackfan

No FAQ available that match "myelodysplastic syndromes anemia refractory with excess of blasts"